TABLE 1.
Baseline demographic data and clinical features at presentation
| Age years | 2.7 (1.1–6.4) |
| Male:female | 1.1:1.0 |
| Born in Europe | 106 (89.8) |
| Born in Europe with one or both parent(s) originating from a high TB incidence country | 57 (48.3) |
| Born outside Europe | 12 (10.2) |
| Africa | 6 (50.0) |
| Asia | 3 (25.0) |
| South America | 3 (25.0) |
| Prior BCG vaccination | |
| Yes | 22 (18.6) |
| No | 80 (67.8) |
| Unknown | 16 (13.6) |
| Known TB contact | |
| Yes | 49 (41.5) |
| No | 67 (56.7) |
| Unknown | 2 (1.7) |
| Constitutional symptoms at presentation | |
| Fever | 99 (83.9) |
| Weight loss | 32 (27.1) |
| Night sweats | 10 (8.5) |
| Neurological symptoms at presentation | |
| Vomiting | 70 (59.3) |
| Altered consciousness | 55 (46.6) |
| Headache | 52 (44.1) |
| Lethargy | 27 (22.9) |
| Cranial nerve palsy | 26 (22.0) |
| Seizures | 25 (21.2) |
| Ataxia | 5 (4.2) |
| Paresis | 3 (2.5) |
Data are presented as median (interquartile range), n or n (%). TB: tuberculosis; BCG: bacille Calmette–Guérin.